Concepedia

Adnan A. Jaigirdar

AA

7

Publications

352

Citations

7

H-Index

2001

Active since

Affiliations

University of California, San Francisco(Current)

Center for Drug Evaluation and Research

National Institutes of Health

United States Food and Drug Administration

Adnan A. Jaigirdar is an author at University of California, San Francisco specializing in medicine, radiation oncology, and cell transplantation.

ORCID

Top concepts

Publications per year

2001–2024

7

Publications

7

Acquisition of CD80 (B7-1) by T Cells

Helen Sabzevari, Judy Kantor, Adnan A. Jaigirdar et al. · The Journal of Immunology · 2001 · 107 citations · Full text

FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer

Sonia Singh, Adnan A. Jaigirdar, Flora Mulkey et al. · Clinical Cancer Research · 2020 · 88 citations · Full text

, , +16

FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review

Paz J. Vellanki, Flora Mulkey, Adnan A. Jaigirdar et al. · Clinical Cancer Research · 2021 · 54 citations · Full text

Preferential Priming of Alloreactive T Cells with Indirect Reactivity

Todd V. Brennan, Adnan A. Jaigirdar, Vunghi Hoang et al. · American Journal of Transplantation · 2009 · 49 citations

, , +4

A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells

Adnan A. Jaigirdar, Steven A. Rosenberg, Maria R. Parkhurst · Journal of Immunotherapy · 2016 · 22 citations · Full text

, , +23

Rows per page

1–5 of 7